Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)
Agency: National Institutes of Health
Assistance Listings
- 93.866 -- Aging Research
- 93.173 -- Research Related to Deafness and Communication Disorders
- 93.399 -- Cancer Control
- 93.839 -- Blood Diseases and Resources Research
- 93.233 -- National Center on Sleep Disorders Research
- 93.361 -- Nursing Research
- 93.394 -- Cancer Detection and Diagnosis Research
- 93.395 -- Cancer Treatment Research
- 93.279 -- Drug Use and Addiction Research Programs
- 93.172 -- Human Genome Research
- 93.393 -- Cancer Cause and Prevention Research
- 93.840 -- Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders
- 93.242 -- Mental Health Research Grants
- 93.273 -- Alcohol Research Programs
- 93.837 -- Cardiovascular Diseases Research
- 93.307 -- Minority Health and Health Disparities Research
- 93.838 -- Lung Diseases Research
- 93.865 -- Child Health and Human Development Extramural Research
- 93.867 -- Vision Research
Open opportunityLast Updated: May 29, 2026
View version history on Grants.gov
Description
The purpose of the Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools is to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for health professional, undergraduate and graduate students and enhancing the research environment at applicant institutions.Eligible institutions must award baccalaureate or advanced science degrees and have received no more than $6 million dollars per year of NIH support (in both direct and F&A/indirect...
costs) in 4 of the last 7 fiscal years. For institutions composed of multiple schools and colleges, the $6 million funding limit is based on the amount of NIH funding received by all the schools and colleges within the institution as a whole.Help determining the Organization Funding Level can be found here or https://grants.nih.gov/grants/funding/r15.htmThis REAP Notice of Funding Opportunity (NOFO) supports investigator-initiated mechanistic and/or minimal risk clinical trials addressing the mission and research interests of the participating NIH institutes. For purposes of this NOFO, minimal risk clinical trials are defined as those that do not require FDA oversight, do not intend to formally establish efficacy, and have low risks to potentially cause physical or psychological harm.
Eligibility
Eligible applicants
Education
- Private institutions of higher education
- Public and state institutions of higher education
Additional information
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Grantor contact information
Description
National Institute on Aging (NIA)
NIA-NOFO-GrantsContacts@nih.gov
NIA-NOFO-GrantsContacts@nih.gov
Documents
| File name | Description | Last updated |
|---|---|---|
| PAR-27-078-Full-Announcement.html | PAR-27-078-Full-Announcement.html | May 29, 2026 06:43 PM UTC |
Link to additional information
--
Closing: October 25, 2027
Award
$--
Program Funding
--
Expected awards
$--
Award Minimum
$375,000
Award Maximum
Funding opportunity number:
PAR-27-078
Cost sharing or matching requirement:
No
Funding instrument type:
Grant
Opportunity Category:
Discretionary
Opportunity Category Explanation:
--
Category of Funding Activity:
Health
Category Explanation:
--
History
Version:
1
Posted date:
May 29, 2026
Archive date:
December 24, 2027
